TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.310
+0.050 (3.97%)
At close: Apr 27, 2026, 4:00 PM EDT
1.350
+0.040 (3.05%)
After-hours: Apr 27, 2026, 6:53 PM EDT
TScan Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$7.00
Upside
+434.35%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $4 → $5 | Buy | Maintains | $4 → $5 | +281.68% | Mar 5, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +434.35% | Nov 13, 2025 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 4, 2025 |
| Needham | Needham | Strong Buy Maintains $9 → $6 | Strong Buy | Maintains | $9 → $6 | +358.02% | Nov 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | +663.36% | May 7, 2025 |
| Needham | Needham | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +587.02% | Apr 8, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $10 | Buy | Initiates | $10 | +663.36% | Mar 14, 2025 |
| Barclays | Barclays | Buy Maintains $14 → $3 | Buy | Maintains | $14 → $3 | +129.01% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +1,045.04% | Mar 6, 2025 |
| Needham | Needham | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +587.02% | Mar 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +1,045.04% | Dec 11, 2024 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +739.69% | Dec 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +1,045.04% | Nov 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +739.69% | Nov 12, 2024 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +739.69% | Nov 6, 2024 |
| Wedbush | Wedbush | Buy Reiterates $10 | Buy | Reiterates | $10 | +663.36% | Aug 13, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.